Cancer patients try home injections to skip clinic visits
NCT ID NCT06015542
Summary
This study is testing whether patients with relapsed multiple myeloma can safely give themselves a cancer drug called elranatamab at home. The main goal is to see if home treatment is safe and practical, and if it improves patients' quality of life by reducing trips to the hospital. The study will enroll 20 patients who have already tried several other standard treatments for their cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Heamatology
RECRUITINGVejle, 7100, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Odense University Hospital
RECRUITINGOdense, 5000, Denmark
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.